Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gentian Diagnostics ASA Director's Dealing 2022

Aug 25, 2022

3604_dirs_2022-08-25_28863637-d441-40a6-bc99-3b46c85ba8f0.html

Director's Dealing

Open in viewer

Opens in your device viewer

Mandatory notification of trade

Mandatory notification of trade

Moss, 25 August 2022

Gentian Diagnostics ASA has today been notified that the following transaction has been completed by a primary insider in Gentian Diagnostics ASA: Monika Neuman, board member and primary insider in Gentian Diagnostics ASA, has today bought 800 shares at an average price of NOK 43.00 per share. After the transaction, Monika Neuman holds 800 shares in Gentian Diagnostics ASA.

This information is subject to the disclosure requirements in the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.

For further information, please contact: Njaal Kind, Group CFO, [email protected], +47 91 90 65 25